← Leaderboards
Timothy D Heath
Plumb Pharmaceuticals, Inc
$381,108
Attributed
$484,467
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $206.7K · FY2014–19$250K$187.5K$125K$62.5K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$484,467 · 2
By mechanism
R43$484,467 · 2
Top collaborators
- Lisa A Krugner-Higby1 shared
Others in their field
Top investigators on “Liposomes”
- Katherine W Ferrara · Stanford University$21,313,923
- James C. Paulson · Scripps Research Institute$15,907,257
- David D McPherson · Northwestern University$13,361,624
- Michael B Zwick · Scripps Research Institute, The$13,172,478
- Gary Fujii · Molecular Express, Inc.$12,568,015
- Casey Koontz · Leidos, Inc.$11,293,734
Research focus
LiposomesOpioidIn VitroLipidsMicrospheresOpiate AddictionDrug FormulationsInjectableIn VivoLeadMaintenance TherapyBuprenorphineAnimalsCanis FamiliarisCharacteristicsAddictionDoseImplantIn Vitro AssayDrug KineticsBloodLaboratoriesCostOral
Grant awards (4)
A 3-month Release Naltrexone for Addiction Treatment$55,000
R43 · FY2019 · DA · contact PI
A 3-month Release Naltrexone for Addiction Treatment$20,186
R43 · FY2019 · DA · contact PI
A 3-month Release Naltrexone for Addiction Treatment$202,563
R43 · FY2018 · DA · contact PI
Long acting injected liposomal buprenorphine for chronic pain/addiction in people$206,718
R43 · FY2014 · DA · contact PI